Footnote and I grant this is a potentially incendiary
Footnote and I grant this is a potentially incendiary comment (heck, the price has been torched so I will feel compelled to whip out my flame-thrower now that the pot has been stirred), however it has not escaped my notice that an entity with much to be gained here as far as triggering events for the DOJ is the FDA itself. The DOJ filing however the chips fall out for NP and Kaz does provide a lot of cover for the FDA. Any sentient Martian dropping in for objective observation could only conclude this was a grievous misstep and embarrassment not to provide an EUA for Leronlimab.
I think it’s a given anything coming out of Vancouver for the FDA from Cytodyn including documents for lifting the hold will be crisp, spell checked, cogent, and above reproach. For this reason I consider lifting of the hold a fait accompli. The hold was after all less about safety and more about lacking integrated safety and risk/benefit analysis…ahem, that was your to-do Amarex.
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...
Continue Reading
Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...
Continue Reading
Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...
Continue Reading
Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...
Continue Reading
Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...
Continue Reading
